S&P 500   4,536.36 (+0.37%)
DOW   35,616.44 (+0.45%)
QQQ   374.64 (-0.22%)
AAPL   148.73 (-0.02%)
MSFT   307.12 (-0.36%)
FB   340.67 (+0.20%)
GOOGL   2,837.23 (-0.96%)
TSLA   865.07 (+0.09%)
AMZN   3,416.01 (-0.82%)
NVDA   220.38 (-1.13%)
BABA   177.18 (+0.10%)
NIO   39.66 (-0.92%)
CGC   14.07 (-1.88%)
GE   105.10 (+0.35%)
AMD   116.13 (-0.17%)
MU   68.33 (+1.12%)
T   25.92 (+1.29%)
F   15.90 (+3.11%)
ACB   7.54 (+1.21%)
DIS   170.39 (-0.46%)
PFE   42.85 (+1.81%)
BA   216.87 (+0.42%)
AMC   40.76 (-0.10%)
S&P 500   4,536.36 (+0.37%)
DOW   35,616.44 (+0.45%)
QQQ   374.64 (-0.22%)
AAPL   148.73 (-0.02%)
MSFT   307.12 (-0.36%)
FB   340.67 (+0.20%)
GOOGL   2,837.23 (-0.96%)
TSLA   865.07 (+0.09%)
AMZN   3,416.01 (-0.82%)
NVDA   220.38 (-1.13%)
BABA   177.18 (+0.10%)
NIO   39.66 (-0.92%)
CGC   14.07 (-1.88%)
GE   105.10 (+0.35%)
AMD   116.13 (-0.17%)
MU   68.33 (+1.12%)
T   25.92 (+1.29%)
F   15.90 (+3.11%)
ACB   7.54 (+1.21%)
DIS   170.39 (-0.46%)
PFE   42.85 (+1.81%)
BA   216.87 (+0.42%)
AMC   40.76 (-0.10%)
S&P 500   4,536.36 (+0.37%)
DOW   35,616.44 (+0.45%)
QQQ   374.64 (-0.22%)
AAPL   148.73 (-0.02%)
MSFT   307.12 (-0.36%)
FB   340.67 (+0.20%)
GOOGL   2,837.23 (-0.96%)
TSLA   865.07 (+0.09%)
AMZN   3,416.01 (-0.82%)
NVDA   220.38 (-1.13%)
BABA   177.18 (+0.10%)
NIO   39.66 (-0.92%)
CGC   14.07 (-1.88%)
GE   105.10 (+0.35%)
AMD   116.13 (-0.17%)
MU   68.33 (+1.12%)
T   25.92 (+1.29%)
F   15.90 (+3.11%)
ACB   7.54 (+1.21%)
DIS   170.39 (-0.46%)
PFE   42.85 (+1.81%)
BA   216.87 (+0.42%)
AMC   40.76 (-0.10%)
S&P 500   4,536.36 (+0.37%)
DOW   35,616.44 (+0.45%)
QQQ   374.64 (-0.22%)
AAPL   148.73 (-0.02%)
MSFT   307.12 (-0.36%)
FB   340.67 (+0.20%)
GOOGL   2,837.23 (-0.96%)
TSLA   865.07 (+0.09%)
AMZN   3,416.01 (-0.82%)
NVDA   220.38 (-1.13%)
BABA   177.18 (+0.10%)
NIO   39.66 (-0.92%)
CGC   14.07 (-1.88%)
GE   105.10 (+0.35%)
AMD   116.13 (-0.17%)
MU   68.33 (+1.12%)
T   25.92 (+1.29%)
F   15.90 (+3.11%)
ACB   7.54 (+1.21%)
DIS   170.39 (-0.46%)
PFE   42.85 (+1.81%)
BA   216.87 (+0.42%)
AMC   40.76 (-0.10%)
TSE:EXE

Extendicare Stock Forecast, Price & News

C$7.20
-0.09 (-1.23 %)
(As of 10/20/2021 02:48 PM ET)
Add
Compare
Today's Range
C$7.18
C$7.30
50-Day Range
C$7.12
C$8.23
52-Week Range
C$5.06
C$8.71
Volume176,215 shs
Average Volume226,842 shs
Market CapitalizationC$644.85 million
P/E Ratio10.62
Dividend Yield6.58%
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive EXE News and Ratings via Email

Sign-up to receive the latest news and ratings for Extendicare and its competitors with MarketBeat's FREE daily newsletter.


Extendicare logo

About Extendicare

Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; retirement living services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as contract and consulting services to third parties. It operates a net of 121 LTC homes and retirement communities, including 69 owned and 52 contract services, as well as home health care operations under the Extendicare, Esprit Lifestyle Communities, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. The company was founded in 1968 and is based in Markham, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Long-Term Care Facilities
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Employees
23,000
Year Founded
N/A

Sales & Book Value

Annual Sales
C$1.23 billion
Cash Flow
C$1.47 per share
Book Value
C$1.34 per share

Profitability

Debt

Price-To-Earnings

Miscellaneous

Market Cap
C$644.85 million
Next Earnings Date
11/11/2021 (Estimated)
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.86 out of 5 stars

Analyst Opinion: 2.1Community Rank: 3.5Dividend Strength: 2.5Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -












Extendicare (TSE:EXE) Frequently Asked Questions

Is Extendicare a buy right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Extendicare in the last twelve months. There are currently 4 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" Extendicare stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in EXE, but not buy additional shares or sell existing shares.
View analyst ratings for Extendicare
or view top-rated stocks.

What stocks does MarketBeat like better than Extendicare?

Wall Street analysts have given Extendicare a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Extendicare wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Extendicare's next earnings date?

Extendicare is scheduled to release its next quarterly earnings announcement on Thursday, November 11th 2021.
View our earnings forecast for Extendicare
.

How were Extendicare's earnings last quarter?

Extendicare Inc. (TSE:EXE) issued its earnings results on Thursday, August, 5th. The company reported $0.01 earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $0.06 by $0.05. The firm had revenue of $307.45 million for the quarter, compared to the consensus estimate of $307.40 million.
View Extendicare's earnings history
.

How has Extendicare's stock price been impacted by COVID-19 (Coronavirus)?

Extendicare's stock was trading at C$6.72 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, EXE shares have increased by 7.1% and is now trading at C$7.20.
View which stocks have been most impacted by COVID-19
.

How often does Extendicare pay dividends? What is the dividend yield for Extendicare?

Extendicare declared a monthly dividend on Thursday, October 28th. Shareholders of record on Monday, November 15th will be paid a dividend of 0.04 per share on Monday, November 15th. This represents a $0.48 dividend on an annualized basis and a yield of 6.67%. The ex-dividend date is Thursday, October 28th.
View Extendicare's dividend history
.

Is Extendicare a good dividend stock?

Extendicare pays an annual dividend of C$0.48 per share and currently has a dividend yield of 6.58%. EXE has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio of Extendicare is 70.80%. This payout ratio is at a healthy, sustainable level, below 75%.
View Extendicare's dividend history.

What price target have analysts set for EXE?

5 equities research analysts have issued 12 month target prices for Extendicare's stock. Their forecasts range from C$7.25 to C$9.00. On average, they anticipate Extendicare's share price to reach C$8.46 in the next year. This suggests a possible upside of 17.6% from the stock's current price.
View analysts' price targets for Extendicare
or view top-rated stocks among Wall Street analysts.

Who are Extendicare's key executives?

Extendicare's management team includes the following people:
  • Dr. Michael R. Guerriere, CEO, Pres & Director (Age 57, Pay $1.11M)
  • Mr. David E. Bacon, Sr. VP & CFO
  • Mr. John Toffoletto, Sr. VP, Chief Legal Officer & Corp. Sec.
  • Ms. Elaine E. Everson, VP of Corp. Devel.
  • Ms. Leslie Sarauer, Sr. VP & Chief HR Officer (Age 59, Pay $517.25k)
  • Mr. Ali Mohammad Mir, VP, ParaMed Operations
  • Ms. Jillian E. Fountain, VP of Investor Relations
  • Ms. Lisa Pearson, VP of Public Affairs
  • Dr. Matthew Morgan, Chief Medical Officer
  • Mr. Bruce Wienberg, Sr. VP of Residential Care Operations

What other stocks do shareholders of Extendicare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Extendicare investors own include Inter Pipeline (IPL), Pembina Pipeline (PPL), BCE (BCE), Chorus Aviation (CHR), Cenovus Energy (CVE), Medical Facilities (DR), Martinrea International (MRE), Air Canada (AC), AltaGas (ALA) and Emera (EMA).

What is Extendicare's stock symbol?

Extendicare trades on the Toronto Stock Exchange (TSX) under the ticker symbol "EXE."

How do I buy shares of Extendicare?

Shares of EXE and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Extendicare's stock price today?

One share of EXE stock can currently be purchased for approximately C$7.20.

How much money does Extendicare make?

Extendicare has a market capitalization of C$644.85 million and generates C$1.23 billion in revenue each year.

How many employees does Extendicare have?

Extendicare employs 23,000 workers across the globe.

What is Extendicare's official website?

The official website for Extendicare is www.extendicare.com.

How can I contact Extendicare?

The company can be reached via phone at 905-470-4000.


This page was last updated on 10/20/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.